KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Liabilities (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Total Liabilities for 7 consecutive years, with $787.8 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 18.75% to $787.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $787.8 million through Dec 2025, up 18.75% year-over-year, with the annual reading at $787.8 million for FY2025, 18.75% up from the prior year.
  • Total Liabilities hit $787.8 million in Q4 2025 for GoodRx Holdings, up from $724.8 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $826.8 million in Q4 2023 to a low of $640.9 million in Q1 2025.
  • Historically, Total Liabilities has averaged $758.8 million across 5 years, with a median of $775.0 million in 2021.
  • Biggest five-year swings in Total Liabilities: fell 27.92% in 2021 and later increased 18.75% in 2025.
  • Year by year, Total Liabilities stood at $775.9 million in 2021, then rose by 1.79% to $789.8 million in 2022, then grew by 4.69% to $826.8 million in 2023, then decreased by 19.77% to $663.4 million in 2024, then rose by 18.75% to $787.8 million in 2025.
  • Business Quant data shows Total Liabilities for GDRX at $787.8 million in Q4 2025, $724.8 million in Q3 2025, and $675.7 million in Q2 2025.